Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species

Clinical Immunology

Volumn 109, Issue 2, 2003, Pages 188-196

  Soos, Jeanne M ^a   Polsky, Rodd M ^a   Keegan, Sean P ^a   Bugelski, Peter ^a,b   Herzyk, Danuta J ^a  

^a GLAXOSMITHKLINE   (United States)

^b CENTOCOR INC   (United States)

Author keywords

Electrochemiluminescence assay; Interleukin 18; Natural antibodies; Neopterin; Nonhuman primates

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON; IBOCTADEKIN; INTERLEUKIN 18 ANTIBODY; NEOPTERIN; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 18; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CELL ACTIVITY; CHIMPANZEE; CONTROLLED STUDY; DATA ANALYSIS; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; EVALUATION; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MONKEY; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHESUS MONKEY; SEROLOGY;

EID: 0242333961     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00180-3     Document Type: Article

References (46)

1. Meager A. Natural autoantibodies to interferons. J. Interferon Cytokine Res. 17:(suppl 1):1997;S51-S53.
2. Bendtzen K., Hansen M.B., Ross C., Svenson M. Detection of autoantibodies to cytokines. Mol. Biotechnol. 14:2000;251-261.
3. Bendtzen K., Hansen M.B., Diamant M., Ross C., Svenson M. Naturally occurring autoantibodies to interleukin-1 alpha, interleukin-6, interleukin-10, and interferon-alpha. J. Interferon Res. 14:1994;157-158.
4. Ross C., Hansen M.B., Schyberg T., Berg K. Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors. Clin. Exp. Immunol. 82:1990;57-62.
5. Kivisakk P., Alm G.V., Tian W.Z., Matusevicius D., Fredrikson S., Link H. Neutralising and binding anti-interferon-beta-I b (IFN-beta-I b) antibodies during IFN-beta-I b treatment of multiple sclerosis. Multiple Sclerosis. 3:1997;184-190.
6. Hansen M.B., Svenson M., Diamant M., Bendtzen K. Anti-interleukin-6 antibodies in normal human serum. Scand. J. Immunol. 33:1991;777-781.
7. Svenson M., Poulsen L.K., Fomsgaard A., Bendtzen K. IgG autoantibodies against interleukin 1 alpha in sera of normal individuals. Scand. J. Immunol. 29:1989;489-492.
8. Balsari A., Caruso A. Natural antibodies to IL-2. Biotherapy. 10:1997;25-28.
9. Fomsgaard A., Svenson M., Bendtzen K. Auto-antibodies to tumor necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand. J. Immunol. 30:1989;219-223.
10. Laricchia-Robbio L., Moscato S., Genua A., Liberati A.M., Revoltella R.P. Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum. J. Cell. Physiol. 173:1997;219-226.
11. Meager A., Vincent A., Newsom-Davis J., Willcox N. Spontaneous neutralising antibodies to interferon-alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet. 350:1997;1596-1597.
12. Meager A., Wadhwa M., Bird C., Dilger P., Thorpe R., Newsom-Davis J., Willcox N. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease. Immunology. 97:1999;526-532.
13. Revoltella R.P. Natural and therapeutically-induced antibodies to cytokines. Biotherapy. 10:1998;321-331.
14. van der Meide P.H., Schellekens H. Anti-cytokine autoantibodies epiphenomenon or critical modulators of cytokine action . Biotherapy. 10:1997;39-48.
15. Akira S. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12:2000;59-63.
16. Dinarello C.A., Novick D., Puren A.J., Fantuzzi G., Shapiro L., Muhl H., Yoon D.Y., Reznikov L.L., Kim S.H., Rubenstein M. Overview of interleukin-18 more than an interferon-gamma inducing factor . J. Leukoc. Biol. 63:1998;658-664.
17. Lebel-Binay S., Berger A., Zinzindohoue F., Cugnenc P., Thiounn N., Fridman W.H., Pages F. Interleukin-18 biological properties and clinical implications . Eur. Cytokine Network. 11:2000;15-26.
18. Puren A.J., Fantuzzi G., Gu Y., Su M.S., Dinarello C.A. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J. Clin. Invest. 101:1998;711-721.
19. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., Ikeda M., Kurimoto M. IFN-gamma-inducing factor is a co-stimulatory factor on the activation of Th1 but not Th2 cells and exerts its effects independently of IL-12. J. Immunol. 158:1997;1541-1550.
20. Micallef M.J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namba M., Tanimoto T., Torigoe K., Fujii M., Ikeda M., Fukuda S., Kurimoto M. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells synergism with interleukin-12 for interferon-gamma production . Eur. J. Immunol. 26:1996;1647-1651.
21. Dao T., Mehal W.Z., Crispe I.N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161:1998;2217-2222.
22. Lauwerys B.R., Renauld J.C., Houssiau F.A. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine. 11:1999;822-830.
23. Singh S.M., Yanagawa H., Hanibuchi M., Miki T., Okamura H., Sone S. Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12. Int. J. Immunopharmacol. 22:2000;35-43.
24. Tanaka F., Hashimoto W., Okamura H., Robbins P.D., Lotze M.T., Tahara H. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Cancer Res. 60:2000;4838-4844.
25. Okamoto I., Kohno K., Tanimoto T., Ikegami H., Kurimoto M. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. J. Immunol. 162:1999;3202-3211.
26. Hashimoto W., Osaki T., Okamura H., Robbins P.D., Kurimoto M., Nagata S., Lotze M.T., Tahara H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J. Immunol. 163:1999;583-589.
27. Hegardt P., Widegren B., Li L., Sjogren B., Kjellman C., Sur I., Sjogren H.O. Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma. Cancer Immunol. Immunother. 50:2001;491-501.
28. M.J. Micallef, H. Yoshida, T. Kawai, T. Hanaya, K. Kohno, S. Arai, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, M. Kurimoto, In vivo antitumor effects of murine interferon-gamma- inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascities, Cancer Immunol. Immunother. 43 (1997) 361-367.
29. Nagai H., Hara I., Horikawa T., Fujii M., Kurimoto M., Kamidono S., Ichihashi M. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. Cancer Invest. 18:2000;206-213.
30. Cao R., Farnebo J., Kurimoto M., Cao Y. Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J. 13:1999;2195-2202.
31. Jonak Z.L., Trulli S., Maier C., McCabe F.L., Kirkpatrick R., Johanson K., Ho Y.S., Elefante L., Chen Y.J., Herbyk D., Lotze M.T., Johnson R.K. High-dose recombinant interleukin-18 induces an effective Thl immune response to murine MOPC-315 plasmacytoma. J. Immunother. 25 Suppl 1:2002;S20-27.
32. Konishi K., Tanabe F., Taniguchi M., Yamauchi H., Tanimoto T., Ikeda M., Orita K., Kurimoto M. A simple and sensitive bioassay for the detection of human interleukin-18/interferon-gamma-inducing factor using human myelomonocytic KG-1 cells. J. Immunol. Methods. 209:1997;187-191.
33. Holmes S., Abrahamson J.A., Al-Mahdi N., Abdel-Meguid S.S., Ho Y.S. Characterization of the in vitro and in vivo activity of monoclonal antibodies to human IL-18. Hybridoma. 19:2000;363-367.
34. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. Interleukin-18 binding protein a novel modulator of the Th1 cytokine response . Immunity. 10:1999;127-136.
35. Hamerlinck F.F.V. Neopterin a review . Exp. Dermatol. 8:1999;176.
36. Weiss G., Murr C., Zoller H., Haun M., Widner B., Ludescher C., Fuchs D. Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin. Exp. Immunol. 116:1999;435-440.
37. J.M. Soos, B.E. Szente, R.P. Polsky, E.R. Gore, S.P. Keegan, B.A. Speal, C.C. Maier, Z.L. Jonak, P.J. Bugelski, D.J. Herzyk, IL-18 induction of neopterin by human and nonhuman primates: identification of an IL-18/neopterin feedback loop by microarray analysis, Manuscript in preparation (2003).
38. D.J. Herzyk, J.M. Soos, C.C. Maier, E.R. Gore, P. Narayanan, K.L. Nadwodny, S. Liu, Z.L. Jonak, P.J. Bugelski, Immunopharmacology of recombinant human interleukin-18 in non-human primates, Cytokine 20 (2002) 38-48.
39. Nell L.J., Hulbert C., Arem R., Marshall R.N., Rogers D.G., Comstock J.P., Ellerhorst J.A., Thomas J.W. Factors affecting the insulin autoantibody ELISA. Autoimmunity. 2:2002;299-309.
40. Kohler H., Keiber-Emmons T., Srinivasan S., Kaveri S., Morrow W.J., Muller S., Kang C.Y., Raychaudhuri S. Revised immune network concepts. Clin. Immunol. Immunopathol. 52:1989;104-116.
41. Klein B., Brailly H. Cytokine-binding proteins stimulating antagonists . Immunol. Today. 16:1995;216-220.
42. Bizzaro N., Tozzoli R., Tonutti E., Piazza A., Manoni F., Ghirardello A., Bassetti D., Villalta D., Pradella M., Rizzotti P. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies a collaborative study with the biomedical industry . J. Immunol. Methods. 219:1998;99-107.
43. Homburger H.A., Cahen Y.D., Griffiths J., Jacob G.L. Detection of antinuclear antibodies comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods . Arch. Pathol. Lab. Med. 122:1998;993-999.
44. Papoian R. Non-specific immunoglobulin interactions may lead to false-positive results in assays for human anti-mouse monoclonal antibodies (HAMA). J. Immunoassay. 13:1992;289-296.
45. Ryff J.C. Clinical investigation of the immunogenicity of interferon-alpha 2a. J. Interferon Cytokine Res. 17:1997;s29-s33.
46. Schellekens H., Ryff J.C., van der Meide P.H. Assays for antibodies to human interferon-alpha: the need for standardization. J. Interferon Cytokine Res. 17:1997;s5-s8.